Pliant Therapeutics (PLRX) Other Gross PP&E Adjustments (2019 - 2025)
Pliant Therapeutics (PLRX) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with -$17.1 million as the latest value for Q4 2025.
- On a quarterly basis, Other Gross PP&E Adjustments rose 8.01% to -$17.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$17.1 million, a 8.01% increase, with the full-year FY2025 number at -$17.1 million, up 8.01% from a year prior.
- Other Gross PP&E Adjustments was -$17.1 million for Q4 2025 at Pliant Therapeutics, down from -$8.4 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $10.4 million in Q3 2023 to a low of -$18.6 million in Q4 2024.
- A 5-year average of -$238950.0 and a median of $3.4 million in 2022 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 230.17% in 2023, then tumbled 778.3% in 2024.
- Pliant Therapeutics' Other Gross PP&E Adjustments stood at $1.5 million in 2021, then plummeted by 43.75% to $832000.0 in 2022, then surged by 230.17% to $2.7 million in 2023, then crashed by 778.3% to -$18.6 million in 2024, then rose by 8.01% to -$17.1 million in 2025.
- Per Business Quant, the three most recent readings for PLRX's Other Gross PP&E Adjustments are -$17.1 million (Q4 2025), -$8.4 million (Q3 2025), and -$9.0 million (Q2 2025).